AZ, IMS To Build Disparate Data Sets Into Broader Outcomes Consensus
Executive Summary
Individual deals with payers or information providers won’t provide pharma with the breadth of outcomes data they need to secure reimbursement for their drugs. A far broader stakeholder consensus is required.